IGF1 and Hepatic fibrosis: Recent studies have shown that YKL-40 is preferentially expressed in areas with active fibrogenesis in patients with hepatic fibrosis, where it may act synergistically with insulin-like growth factor I to stimulate the growth of fibroblasts [12].